What we do
We are developing Prolanta™, a targeted therapeutic protein for the treatment of ovarian, breast and other cancers.
Oncolix has been strategically tied up with many other renowned organizations to get supported in terms of Technological…
Oncolix always had a thirst for participating in International conferences which provides a platform to improve…
Human Prolactin and Cancer
Human prolactin is a single-chain polypeptide of 199 amino acids with a molecular weight of approximately 23,000 Daltons.
Ovarian Cancer and Prolanta™
Ovarian cancer is the fourth leading cause of cancer-related death in women in the US and the leading cause of
Prolanta™ (referenced in the scientific literature as G129R) is a prolactin receptor antagonist with a single amino acid mutation.
Human prolactin binds with its cell surface receptor (the prolactin receptor) through dimerization (or binding two receptors simultaneously), activating various pathways that